BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32467069)

  • 21. Crossroads of telomere biology and anticancer drug discovery.
    Seimiya H
    Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Developments in Small-Molecule Ligands of Medicinal Relevance for Harnessing the Anticancer Potential of G-Quadruplexes.
    Savva L; Georgiades SN
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G-Quadruplex-Forming Aptamers-Characteristics, Applications, and Perspectives.
    Roxo C; Kotkowiak W; Pasternak A
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31640176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligands stimulating antitumour immunity as the next G-quadruplex challenge.
    Miglietta G; Marinello J; Russo M; Capranico G
    Mol Cancer; 2022 Sep; 21(1):180. PubMed ID: 36114513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity Chromatography-Based Assays for the Screening of Potential Ligands Selective for G-Quadruplex Structures.
    Platella C; Napolitano E; Riccardi C; Musumeci D; Montesarchio D
    ChemistryOpen; 2022 May; 11(5):e202200090. PubMed ID: 35608081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of selective G-quadruplex ligands as potential anticancer agents.
    Tan JH; Gu LQ; Wu JY
    Mini Rev Med Chem; 2008 Oct; 8(11):1163-78. PubMed ID: 18855731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topologies of G-quadruplex: Biological functions and regulation by ligands.
    Ma Y; Iida K; Nagasawa K
    Biochem Biophys Res Commun; 2020 Oct; 531(1):3-17. PubMed ID: 31948752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
    Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quadruplex-forming oligonucleotides as tools in anticancer therapy and aptamers design: energetic aspects.
    Petraccone L; Barone G; Giancola C
    Curr Med Chem Anticancer Agents; 2005 Sep; 5(5):463-75. PubMed ID: 16178773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents.
    Che T; Wang YQ; Huang ZL; Tan JH; Huang ZS; Chen SB
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29473874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-quadruplexes: targets and tools in anticancer drug design.
    Düchler M
    J Drug Target; 2012 Jun; 20(5):389-400. PubMed ID: 22424091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomeric G-quadruplex architecture and interactions with potential drugs.
    Sissi C; Palumbo M
    Curr Pharm Des; 2014; 20(41):6489-509. PubMed ID: 24975609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and development of anticancer aptamers.
    Ireson CR; Kelland LR
    Mol Cancer Ther; 2006 Dec; 5(12):2957-62. PubMed ID: 17172400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unlocking G-Quadruplexes as Targets and Tools against COVID-19.
    Qin G; Zhao C; Yang J; Wang Z; Ren J; Qu X
    Chin J Chem; 2022 Dec; ():. PubMed ID: 36711116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G-quadruplex ligands as therapeutic agents against cancer, neurological disorders and viral infections.
    Yan MP; Wee CE; Yen KP; Stevens A; Wai LK
    Future Med Chem; 2023 Nov; 15(21):1987-2009. PubMed ID: 37933551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
    Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential.
    Gatto B; Palumbo M; Sissi C
    Curr Med Chem; 2009; 16(10):1248-65. PubMed ID: 19355883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
    Bates PJ; Laber DA; Miller DM; Thomas SD; Trent JO
    Exp Mol Pathol; 2009 Jun; 86(3):151-64. PubMed ID: 19454272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid⁻Protein Interaction.
    Sun ZY; Wang XN; Cheng SQ; Su XX; Ou TM
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.